The fund was one of the first funds to be launched when the firm was established. Benchmarked against the MSCI UK Index, it is a portfolio of UK companies with strong structural growth opportunities and attractive cash flows.
 

The fund:
  • Is overseen by a highly experienced team with complementary skillsets

  • Focuses on companies with high and sustainable returns on capital with structural growth opportunities

  • Is a concentrated portfolio with a long-term time horizon

December 2020 - Latest commentary
 

Equity markets continued to rally despite rising Covid-19 infections in the US and UK. Anticipation of further fiscal stimulus and imminent vaccine roll-outs were the main drivers. In the UK, Brexit trade negotiations went down to the wire, but an acceptable trade deal was finally agreed and a no-deal Brexit at month-end was averted. This helped Sterling to rally, thus supporting domestic stocks. More generally, economically sensitive shares were the strongest performers in the UK, with mining stocks being the top performers while the healthcare sector was a notable poor performer.

Our portfolio out-performed the index, capping another good quarter for the fund and a very strong year for relative out-performance, though the overall UK market has undoubtedly been disappointing relative to global equities.

The main positive factor this month was good stock selection, particularly in the financials sector, helped by strong gains in Integrafin, Prudential, Barclays and OneSavings Bank, while not holding HSBC was also beneficial. Other key stocks helping were Flutter Group, which continues to benefit from US on-line gaming growth, while gains in Howden Joinery and Taylor Wimpey reflected good current trading and optimism on the recovery prospects for the domestic UK economy. The main stock detracting was Sage Group, where downgrades to growth following last month’s disappointing results and weaker margin guidance continued to weigh on the shares.

We continue to be comfortable with the current portfolio, the only change this month being an addition to our existing significant position in Integrafin. Recent results have only served to strengthen our confidence in the excellent long term growth prospects for this leading UK investment platform business.

As we enter 2021, the near term drag on the economy from a third national lockdown is clearly unwelcome. From an investment standpoint, however, there are grounds for medium term optimism. The vaccine roll-out should start to make a material difference towards reducing the Covid related deaths quite quickly (being focused on the most vulnerable population sub-groups). We also know that lockdowns do work; although hitherto the benefits have been temporary, the vaccine should bring a more sustained suppression of infections. The UK economy should be recovering strongly by the spring, and this prospect will support a further equity market rally. Beyond this, further gains are possible provided government policy remains supportive.

Previous months’ commentaries are contained within the fund factsheets.

Meet the Sanlam UK Equities Team

Chris Rodgers
Chris Rodgers
Head of UK Equities
View profile
Andrew Evans, CFA
Andrew Evans, CFA
Fund Manager
View profile
Mark Boucher
Mark Boucher
Fund Manager
View profile
Mark Swain
Mark Swain
Fund Manager
View profile
Fund factsheets
Monthly performance update
Find out more
Fund supplements
Regulatory documents
Find out more
Fund KIIDs
Key investor information
Find out more
Quarterly newsletters
Fund and market updates
Find out more

Fund disclaimer

Past performance is not a guide to future performance. Do remember that the value of an investment and the income generated from them can fall as well as rise and is not guaranteed, therefore, you may not get back the amount originally invested and potentially risk total loss of capital. A table with five years performance is available in the fund factsheets below.

The fund invests geographically in a narrow range, there is an increased risk of volatility which may result in frequent rises and falls in the Fund's share price.

Please agree to proceed. By doing so you agree that you have read and understood the foregoing disclaimer and confirm that you are a professional investor.

Please navigate to a service or product page and add the document to your brochure to continue.

Back
Name your brochure
Your details
Thank you!

Your brochure is on its way.

Brochure Confirmation - your brochure is on its way.

We hope you find this useful.

The value of investments and any income from them can fall and you may get back less than you invested.